Skip to main content

Table 2 General linear regression models for the associations between remnant cholesterol and iron status

From: Remnant cholesterol, iron status and diabetes mellitus: a dose–response relationship and mediation analysis

 

Model 1

Model 2

Model 3

SF, ng/ml

 Each 1 mmol/L increase in RC

82.63 (75.85–89.41)

65.97 (59.35–72.58)

73.14 (65.79–80.49)

 Q1 (0.01–0.19)

Reference

Reference

Reference

 Q2 (0.20–0.36)

18.87 (7.02–30.72)

15.27 (4.08–26.45)

15.03 (3.76–26.29)

 Q3 (0.37–0.65)

51.73 (39.92–63.54)

39.38 (28.13–50.62)

38.48 (26.90–50.05)

 Q4 (0.66–8.68)

113.53 (101.65–125.42)

86.15 (74.53–97.78)

86.74 (74.05–99.43)

 P for trend

 < 0.001

 < 0.001

 < 0.001

TBI, mg/kg

 Each 1 mmol/L increase in RC

1.91 (1.74–2.08)

1.42 (1.26–1.57)

1.61 (1.44–1.78)

 Q1 (0.01–0.19)

Reference

Reference

Reference

 Q2 (0.20–0.36)

0.68 (0.39–0.97)

0.57 (0.32–0.83)

0.57 (0.31–0.83)

 Q3 (0.37–0.65)

1.56 (1.27–1.85)

1.19 (0.93–1.44)

1.16 (0.89–1.42)

 Q4 (0.66–8.68)

2.96 (2.67–3.25)

2.15 (1.89–2.42)

2.21 (1.92–2.50)

 P for trend

 < 0.001

 < 0.001

 < 0.001

  1. Model 1: unadjusted;
  2. Model 2: adjusted for age, sex and BMI;
  3. Model 3: adjusted for age, sex, BMI, residence, occupation, education, smoking, alcohol consumption, eGFR, LDL-C, HDL-C, average energy intake, average carbohydrate intake, average fat intake, and average protein intake
  4. RC Remnant cholesterol, SF Serum ferritin, TBI Total body iron